Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Dentsply Sirona (XRAY) Restructuring Costs (2016 - 2025)

Dentsply Sirona's Restructuring Costs history spans 17 years, with the latest figure at $6.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Restructuring Costs fell 25.0% year-over-year to $6.0 million, compared with a TTM value of $24.0 million through Dec 2025, down 54.72%, and an annual FY2025 reading of $24.0 million, down 54.72% over the prior year.
  • Restructuring Costs for Q4 2025 was $6.0 million at Dentsply Sirona, up from $5.0 million in the prior quarter.
  • The five-year high for Restructuring Costs was $59.0 million in Q1 2023, with the low at -$3.0 million in Q4 2023.
  • Average Restructuring Costs over 5 years is $8.8 million, with a median of $5.0 million recorded in 2021.
  • Biggest YoY gain for Restructuring Costs was 1866.67% in 2023; the steepest drop was 400.0% in 2023.
  • Tracing XRAY's Restructuring Costs over 5 years: stood at $6.0 million in 2021, then plummeted by 83.33% to $1.0 million in 2022, then plummeted by 400.0% to -$3.0 million in 2023, then soared by 366.67% to $8.0 million in 2024, then fell by 25.0% to $6.0 million in 2025.
  • Per Business Quant, the three most recent readings for XRAY's Restructuring Costs are $6.0 million (Q4 2025), $5.0 million (Q3 2025), and $4.0 million (Q2 2025).